Nichanan Osataphan

Chiang Mai, Thailand

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Normal myocardial T1, T2 mapping and extracellular volume at 1.5 T in adult Thai population.

Normal myocardial T1, T2 mapping and extracellular volume at 1.5 T in adult Thai population.

Journal: Journal of applied clinical medical physics
Published: January 11, 2026

Impact of Controlled Hypothermic Preservation on Early Outcomes in Heart Transplant Recipients.

Impact of Controlled Hypothermic Preservation on Early Outcomes in Heart Transplant Recipients.

Journal: Journal of cardiac failure
Published: October 23, 2025

Validation of ARIC heart failure risk score in an Asian population: Results from the CORE-Thailand registry.

Validation of ARIC heart failure risk score in an Asian population: Results from the CORE-Thailand registry.

Journal: Clinical medicine (London, England)
Published: November 28, 2024

Lung Cancer and Cardiovascular Disease: Common Pathophysiology and Treatment-Emergent Toxicity.

Lung Cancer and Cardiovascular Disease: Common Pathophysiology and Treatment-Emergent Toxicity.

Journal: JACC. CardioOncology
Published: November 08, 2024

Changes in Mitochondrial Function and Cell Death Patterns in Peripheral Blood Mononuclear Cells during Trastuzumab Treatment Following Doxorubicin Chemotherapy.

Changes in Mitochondrial Function and Cell Death Patterns in Peripheral Blood Mononuclear Cells during Trastuzumab Treatment Following Doxorubicin Chemotherapy.

Journal: Biomedicines
Published: August 11, 2024

Phenotypes of Myocardial Dysfunction on Serial Echocardiography and CMR in Women With Early-Stage Breast Cancer.

Phenotypes of Myocardial Dysfunction on Serial Echocardiography and CMR in Women With Early-Stage Breast Cancer.

Journal: JACC. Cardiovascular imaging
Published: July 25, 2024

Sodium-Glucose Cotransporter 2 Inhibitors During Cancer Therapy: Benefits, Risks, and Ongoing Clinical Trials.

Sodium-Glucose Cotransporter 2 Inhibitors During Cancer Therapy: Benefits, Risks, and Ongoing Clinical Trials.

Journal: Current oncology reports
Published: July 02, 2024

Safety of Continuing Trastuzumab for Mild Cardiotoxicity: A Cardiovascular Magnetic Resonance Imaging Study.

Safety of Continuing Trastuzumab for Mild Cardiotoxicity: A Cardiovascular Magnetic Resonance Imaging Study.

Journal: CJC open
Published: February 06, 2024

Changes in blood metabolomes as potential markers for severity and prognosis in doxorubicin-induced cardiotoxicity: a study in HER2-positive and HER2-negative breast cancer patients.

Changes in blood metabolomes as potential markers for severity and prognosis in doxorubicin-induced cardiotoxicity: a study in HER2-positive and HER2-negative breast cancer patients.

Journal: Journal of translational medicine
Published: December 17, 2023

Effect of Beta-Blocker on Long-Term Major Cardiovascular Events in High Atherosclerotic Risk Population.

Effect of Beta-Blocker on Long-Term Major Cardiovascular Events in High Atherosclerotic Risk Population.

Journal: Cardiovascular drugs and therapy
Published: August 07, 2023

Effect of renin angiotensin system inhibitors on long-term major cardiovascular outcomes in patients with high atherosclerotic cardiovascular risk.

Effect of renin angiotensin system inhibitors on long-term major cardiovascular outcomes in patients with high atherosclerotic cardiovascular risk.

Journal: Scientific reports
Published: June 20, 2023

Effects of metformin and donepezil on the prevention of doxorubicin-induced cardiotoxicity in breast cancer: a randomized controlled trial.

Effects of metformin and donepezil on the prevention of doxorubicin-induced cardiotoxicity in breast cancer: a randomized controlled trial.

Journal: Scientific reports
Published: March 13, 2023
Showing 1-12 of 19

Last Updated: 09/26/2026